<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://scemsprotocols.com/scems/index.php?action=history&amp;feed=atom&amp;title=Adenosine</id>
	<title>Adenosine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://scemsprotocols.com/scems/index.php?action=history&amp;feed=atom&amp;title=Adenosine"/>
	<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Adenosine&amp;action=history"/>
	<updated>2026-04-05T06:03:25Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://scemsprotocols.com/scems/index.php?title=Adenosine&amp;diff=1395&amp;oldid=prev</id>
		<title>Treloars: /* Section 8 - MEDICATION GUIDELINES */</title>
		<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Adenosine&amp;diff=1395&amp;oldid=prev"/>
		<updated>2020-04-23T23:40:39Z</updated>

		<summary type="html">&lt;p&gt;&lt;span class=&quot;autocomment&quot;&gt;Section 8 - MEDICATION GUIDELINES&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 23:40, 23 April 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l18&quot;&gt;Line 18:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Heart transplant patients may only require a smaller dosage and patients on Theophylline based medications may require larger dosage, contact MEDICAL CONTROL for consult.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Heart transplant patients may only require a smaller dosage and patients on Theophylline based medications may require larger dosage, contact MEDICAL CONTROL for consult.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;DOSAGE:&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;DOSAGE:&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* IV &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;6 &lt;/del&gt;mg by rapid IV bolus, if no results repeat 1-2 minutes later as 12 mg rapid IV bolus. Maximum total dose &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;18 &lt;/del&gt;mg.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* IV &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;12 &lt;/ins&gt;mg by rapid IV bolus, if no results repeat 1-2 minutes later as 12 mg rapid IV bolus. Maximum total dose &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;24 &lt;/ins&gt;mg.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Pediatrics - Refer to Handtevy System for patient specific dosage&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Pediatrics - Refer to Handtevy System for patient specific dosage&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Premies - 13 y/o: 0.1 mg/kg (1st dose), 0.2 mg/kg (2nd dose)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Premies - 13 y/o: 0.1 mg/kg (1st dose), 0.2 mg/kg (2nd dose)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Treloars</name></author>
	</entry>
	<entry>
		<id>https://scemsprotocols.com/scems/index.php?title=Adenosine&amp;diff=1383&amp;oldid=prev</id>
		<title>Treloars: Created page with &quot;==Section 8 - MEDICATION GUIDELINES== ===ANTIARRHYTHMICS===  ====Adenosine (ADENOCARD) / Antiarrhythmic==== &#039;&#039;&#039;DESCRIPTION/ACTION:&#039;&#039;&#039; * It is a natural occurring agent that ca...&quot;</title>
		<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Adenosine&amp;diff=1383&amp;oldid=prev"/>
		<updated>2020-04-23T23:31:09Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Section 8 - MEDICATION GUIDELINES== ===ANTIARRHYTHMICS===  ====Adenosine (ADENOCARD) / Antiarrhythmic==== &amp;#039;&amp;#039;&amp;#039;DESCRIPTION/ACTION:&amp;#039;&amp;#039;&amp;#039; * It is a natural occurring agent that ca...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Section 8 - MEDICATION GUIDELINES==&lt;br /&gt;
===ANTIARRHYTHMICS===&lt;br /&gt;
&lt;br /&gt;
====Adenosine (ADENOCARD) / Antiarrhythmic====&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DESCRIPTION/ACTION:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* It is a natural occurring agent that can &amp;quot;chemically cardiovert&amp;quot; Paroxysmal Supraventricular Tachycardia (PSVT) to a normal sinus rhythm.&lt;br /&gt;
* It has a half-life of 5 seconds and does not cause hypotension like Verapamil.&lt;br /&gt;
* Restores normal sinus rhythm by interrupting re-entrant pathways in the AV node.&lt;br /&gt;
* Slows conduction time through the AV node.&lt;br /&gt;
* Produces coronary artery vasodialation.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;INDICATIONS:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* [[Supraventricular Tachycardia|Narrow complex (PSVT)]] refractory to vagal maneuvers.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;CONTRAINDICATIONS:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* 2nd and 3rd Degree Heart Block, Sick Sinus Syndrome, or known hypersensitivity to the medication.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;PRECAUTIONS:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* It may cause transient arrhythmias.&lt;br /&gt;
* It may cause bronchospasm in asthma patients.&lt;br /&gt;
* Heart transplant patients may only require a smaller dosage and patients on Theophylline based medications may require larger dosage, contact MEDICAL CONTROL for consult.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DOSAGE:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* IV 6 mg by rapid IV bolus, if no results repeat 1-2 minutes later as 12 mg rapid IV bolus. Maximum total dose 18 mg.&lt;br /&gt;
* Pediatrics - Refer to Handtevy System for patient specific dosage&lt;br /&gt;
** Premies - 13 y/o: 0.1 mg/kg (1st dose), 0.2 mg/kg (2nd dose)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Medication Guidelines|Adenosine]]&lt;/div&gt;</summary>
		<author><name>Treloars</name></author>
	</entry>
</feed>